- Home
- WFF vs ALLR Comparison
WFF vs ALLR Comparison
Compare WFF & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- ALLR
- Stock Information
- Founded
- WFF 1984
- ALLR 2004
- Country
- WFF Malaysia
- ALLR United States
- Employees
- WFF N/A
- ALLR N/A
- Industry
- WFF Miscellaneous manufacturing industries
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- WFF Consumer Discretionary
- ALLR Health Care
- Exchange
- WFF Nasdaq
- ALLR Nasdaq
- Market Cap
- WFF 18.3M
- ALLR 20.2M
- IPO Year
- WFF 2025
- ALLR N/A
- Fundamental
- Price
- WFF $0.62
- ALLR $1.20
- Analyst Decision
- WFF
- ALLR Strong Buy
- Analyst Count
- WFF 0
- ALLR 1
- Target Price
- WFF N/A
- ALLR $9.25
- AVG Volume (30 Days)
- WFF 60.5K
- ALLR 241.3K
- Earning Date
- WFF 04-30-2026
- ALLR 11-14-2025
- Dividend Yield
- WFF N/A
- ALLR N/A
- EPS Growth
- WFF N/A
- ALLR N/A
- EPS
- WFF 0.00
- ALLR N/A
- Revenue
- WFF $4,572,290.00
- ALLR N/A
- Revenue This Year
- WFF N/A
- ALLR N/A
- Revenue Next Year
- WFF N/A
- ALLR N/A
- P/E Ratio
- WFF $115.59
- ALLR N/A
- Revenue Growth
- WFF N/A
- ALLR N/A
- 52 Week Low
- WFF $0.45
- ALLR $0.61
- 52 Week High
- WFF $29.26
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- ALLR 38.56
- Support Level
- WFF N/A
- ALLR $1.09
- Resistance Level
- WFF N/A
- ALLR $1.32
- Average True Range (ATR)
- WFF 0.00
- ALLR 0.10
- MACD
- WFF 0.00
- ALLR -0.01
- Stochastic Oscillator
- WFF 0.00
- ALLR 22.50
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.